JP2014532416A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532416A5
JP2014532416A5 JP2014539105A JP2014539105A JP2014532416A5 JP 2014532416 A5 JP2014532416 A5 JP 2014532416A5 JP 2014539105 A JP2014539105 A JP 2014539105A JP 2014539105 A JP2014539105 A JP 2014539105A JP 2014532416 A5 JP2014532416 A5 JP 2014532416A5
Authority
JP
Japan
Prior art keywords
murine
human
endogenous
gene
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014539105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532416A (ja
JP6120451B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/062379 external-priority patent/WO2013063556A1/en
Publication of JP2014532416A publication Critical patent/JP2014532416A/ja
Publication of JP2014532416A5 publication Critical patent/JP2014532416A5/ja
Application granted granted Critical
Publication of JP6120451B2 publication Critical patent/JP6120451B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014539105A 2011-10-28 2012-10-29 ヒト化il−6および/またはil−6受容体 Active JP6120451B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161552900P 2011-10-28 2011-10-28
US61/552,900 2011-10-28
US201161556579P 2011-11-07 2011-11-07
US61/556,579 2011-11-07
PCT/US2012/062379 WO2013063556A1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016224713A Division JP2017035115A (ja) 2011-10-28 2016-11-18 ヒト化il−6および/またはil−6受容体

Publications (3)

Publication Number Publication Date
JP2014532416A JP2014532416A (ja) 2014-12-08
JP2014532416A5 true JP2014532416A5 (https=) 2015-12-03
JP6120451B2 JP6120451B2 (ja) 2017-04-26

Family

ID=47295138

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014539105A Active JP6120451B2 (ja) 2011-10-28 2012-10-29 ヒト化il−6および/またはil−6受容体
JP2016224713A Pending JP2017035115A (ja) 2011-10-28 2016-11-18 ヒト化il−6および/またはil−6受容体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016224713A Pending JP2017035115A (ja) 2011-10-28 2016-11-18 ヒト化il−6および/またはil−6受容体

Country Status (27)

Country Link
US (10) US8878001B2 (https=)
EP (2) EP2663575B1 (https=)
JP (2) JP6120451B2 (https=)
KR (2) KR102234632B1 (https=)
CN (2) CN108866101A (https=)
AU (1) AU2015207889B2 (https=)
BR (1) BR112014008529A2 (https=)
CA (1) CA2853731C (https=)
CY (2) CY1116614T1 (https=)
DK (2) DK2818478T3 (https=)
ES (2) ES2624605T3 (https=)
HR (2) HRP20141192T1 (https=)
HU (1) HUE033400T2 (https=)
IL (4) IL231896B (https=)
IN (1) IN2014CN03920A (https=)
LT (1) LT2818478T (https=)
MX (1) MX358390B (https=)
MY (2) MY172726A (https=)
PL (2) PL2663575T3 (https=)
PT (2) PT2663575E (https=)
RS (2) RS55949B1 (https=)
RU (2) RU2751240C2 (https=)
SG (3) SG10202100485XA (https=)
SI (2) SI2818478T1 (https=)
SM (2) SMT201700222T1 (https=)
WO (1) WO2013063556A1 (https=)
ZA (1) ZA201402635B (https=)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2485583T (pt) 2009-10-06 2016-09-22 Univ Yale Ratinhos geneticamente modificados e enxerto
MX350385B (es) 2011-02-15 2017-09-04 Regeneron Pharma Ratones de m-csf humanizada.
WO2013063556A1 (en) 2011-10-28 2013-05-02 Regeneron Pharmaceuticals, Inc. Humanized il-6 and il-6 receptor
US20130261016A1 (en) * 2012-03-28 2013-10-03 Meso Scale Technologies, Llc Diagnostic methods for inflammatory disorders
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
IN2015DN02032A (https=) 2012-09-07 2015-08-14 Univ Yale
WO2014042251A1 (ja) * 2012-09-13 2014-03-20 中外製薬株式会社 遺伝子ノックイン非ヒト動物
CA2887706C (en) 2012-11-05 2022-08-02 Regeneron Pharmaceuticals Genetically modified non-human animals and methods of use thereof
KR102714111B1 (ko) 2013-02-20 2024-10-11 리제너론 파아마슈티컬스, 인크. 사람화된 t-세포 보조-수용체를 발현하는 마우스
PL2958937T3 (pl) 2013-02-22 2019-01-31 Regeneron Pharmaceuticals, Inc. Myszy ekspresjonujące humanizowany główny układ zgodności tkankowej
GB2513884B (en) 2013-05-08 2015-06-17 Univ Bristol Method and apparatus for producing an acoustic field
CN105592695B (zh) * 2013-09-23 2018-04-10 瑞泽恩制药公司 具有人源化信号调节蛋白基因的非人动物
ES2715949T3 (es) 2013-10-15 2019-06-07 Regeneron Pharma Animales con IL-15 humanizada
SG10201811701YA (en) * 2013-11-19 2019-01-30 Regeneron Pharma Non-human animals having a humanized a proliferation-inducing ligand gene
CA2929846C (en) 2013-11-19 2020-09-15 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
US9612658B2 (en) 2014-01-07 2017-04-04 Ultrahaptics Ip Ltd Method and apparatus for providing tactile sensations
WO2016039801A1 (en) 2014-01-31 2016-03-17 Boehringer Ingelheim International Gmbh Novel anti-baff antibodies
HUE051088T2 (hu) 2014-04-08 2021-03-01 Regeneron Pharma Humanizált FC-gamma receptorokkal rendelkezõ nem humán élõlények
SG10202003996YA (en) 2014-05-05 2020-06-29 Regeneron Pharma Humanized c5 and c3 animals
NO2785538T3 (https=) * 2014-05-07 2018-08-04
SG10202002187WA (en) 2014-05-19 2020-04-29 Regeneron Pharma Genetically modified non-human animals expressing human epo
US9497945B2 (en) * 2014-05-30 2016-11-22 Regeneron Pharmaceuticals, Inc. Humanized dipeptidyl peptidase IV (DPP4) animals
ES2783424T3 (es) * 2014-06-19 2020-09-17 Regeneron Pharma Animales no humanos que tienen un gen de muerte celular programada 1 humanizado
GB2530036A (en) 2014-09-09 2016-03-16 Ultrahaptics Ltd Method and apparatus for modulating haptic feedback
RU2020122439A (ru) 2014-11-24 2020-09-24 Регенерон Фармасьютикалз, Инк. Не относящиеся к человеку животные, экспрессирующие гуманизированный комплекс cd3
SI3086637T1 (sl) * 2014-12-05 2019-04-30 Regeneron Pharmaceuticals, Inc. Nehumane živali s humaniziranim označevalcem diferenciacije gena CD47
HUE052606T2 (hu) 2014-12-09 2021-05-28 Regeneron Pharma Humanizált differenciációs klaszter 274 génnel rendelkezõ nem humán állatok
SG11201706527QA (en) 2015-02-20 2017-09-28 Ultrahaptics Ip Ltd Algorithm improvements in a haptic system
WO2016132144A1 (en) 2015-02-20 2016-08-25 Ultrahaptics Ip Limited Perceptions in a haptic system
CN113349159B (zh) 2015-04-06 2022-11-11 瑞泽恩制药公司 非人动物中的人源化t细胞介导的免疫应答
KR102658190B1 (ko) 2015-04-13 2024-04-17 리제너론 파마슈티칼스 인코포레이티드 인간화된 sirpa-il15 녹인 마우스 및 이의 이용 방법
US10818162B2 (en) 2015-07-16 2020-10-27 Ultrahaptics Ip Ltd Calibration techniques in haptic systems
SG11201803409UA (en) 2015-11-20 2018-05-30 Regeneron Pharma Non-human animals having a humanized lymphocyte-activation gene 3
AU2016365834B2 (en) 2015-12-08 2023-09-28 Regeneron Pharmaceuticals, Inc. Compositions and methods for internalizing enzymes
US11189140B2 (en) 2016-01-05 2021-11-30 Ultrahaptics Ip Ltd Calibration and detection techniques in haptic systems
MX2018009513A (es) 2016-02-04 2019-01-31 Regeneron Pharma Animales no humanos que tienen un gen angptl8 modificado genéticamente.
CN109068621B (zh) 2016-02-29 2021-07-20 再生元制药公司 具有人源化的tmprss基因的啮齿类动物
HUE061619T2 (hu) 2016-06-03 2023-07-28 Regeneron Pharma Exogén terminális dezoxinukleotid-transzferázt expresszáló rágcsálók
US10531212B2 (en) 2016-06-17 2020-01-07 Ultrahaptics Ip Ltd. Acoustic transducers in haptic systems
US10268275B2 (en) 2016-08-03 2019-04-23 Ultrahaptics Ip Ltd Three-dimensional perceptions in haptic systems
US10755538B2 (en) 2016-08-09 2020-08-25 Ultrahaptics ilP LTD Metamaterials and acoustic lenses in haptic systems
CN107815467B (zh) * 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
US10943578B2 (en) 2016-12-13 2021-03-09 Ultrahaptics Ip Ltd Driving techniques for phased-array systems
US10497358B2 (en) 2016-12-23 2019-12-03 Ultrahaptics Ip Ltd Transducer driver
CN108467873B (zh) 2017-03-17 2020-03-13 百奥赛图江苏基因生物技术有限公司 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用
WO2018177441A1 (en) 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
CN108588126B (zh) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Cd47基因人源化改造动物模型的制备方法及应用
MX394999B (es) 2017-09-29 2025-03-24 Regeneron Pharma Animales no humanos que comprenden un locus ttr humanizado y metodos de uso
US11531395B2 (en) 2017-11-26 2022-12-20 Ultrahaptics Ip Ltd Haptic effects from focused acoustic fields
IL310006A (en) 2017-11-30 2024-03-01 Regeneron Pharma Non-human animals containing a humanized TRKB locus
EP3729418B1 (en) 2017-12-22 2024-11-20 Ultrahaptics Ip Ltd Minimizing unwanted responses in haptic systems
EP3729417B1 (en) 2017-12-22 2025-09-10 Ultrahaptics Ip Ltd Tracking in haptic systems
KR20250121150A (ko) 2018-03-26 2025-08-11 리제너론 파마슈티칼스 인코포레이티드 치료제를 시험하기 위한 인간화된 설치류
SG11202010752VA (en) 2018-05-02 2020-11-27 Ultrahaptics Ip Ltd Blocking plate structure for improved acoustic transmission efficiency
IL278267B2 (en) * 2018-07-16 2025-02-01 Regeneron Pharma Non-human animal models of DITRA disease and their uses
US11098951B2 (en) 2018-09-09 2021-08-24 Ultrahaptics Ip Ltd Ultrasonic-assisted liquid manipulation
US11378997B2 (en) 2018-10-12 2022-07-05 Ultrahaptics Ip Ltd Variable phase and frequency pulse-width modulation technique
WO2020125639A1 (en) * 2018-12-17 2020-06-25 Biocytogen Jiangsu Co., Ltd. Genetically modified non-human animal with human or chimeric genes
EP3906462B1 (en) 2019-01-04 2025-06-18 Ultrahaptics IP Ltd Mid-air haptic textures
US12373033B2 (en) 2019-01-04 2025-07-29 Ultrahaptics Ip Ltd Mid-air haptic textures
WO2020147829A1 (zh) * 2019-01-17 2020-07-23 北京百奥赛图基因生物技术有限公司 人源化转基因动物
ES2966625T3 (es) 2019-04-04 2024-04-23 Regeneron Pharma Roedores que comprenden un locus del factor de coagulación 12 humanizado
US11842517B2 (en) 2019-04-12 2023-12-12 Ultrahaptics Ip Ltd Using iterative 3D-model fitting for domain adaptation of a hand-pose-estimation neural network
JP7699749B2 (ja) * 2019-05-27 2025-06-30 株式会社トランスジェニックグループ エクソンヒト化マウス
US11891618B2 (en) 2019-06-04 2024-02-06 Regeneron Pharmaceuticals, Inc. Mouse comprising a humanized TTR locus with a beta-slip mutation and methods of use
US11622547B2 (en) 2019-06-07 2023-04-11 Regeneran Pharmaceuticals, Inc. Genetically modified mouse that expresses human albumin
CA3154040A1 (en) 2019-10-13 2021-04-22 Benjamin John Oliver LONG Dynamic capping with virtual microphones
US11374586B2 (en) 2019-10-13 2022-06-28 Ultraleap Limited Reducing harmonic distortion by dithering
US11169610B2 (en) 2019-11-08 2021-11-09 Ultraleap Limited Tracking techniques in haptic systems
CN111304246B (zh) * 2019-12-17 2021-05-04 百奥赛图江苏基因生物技术有限公司 一种人源化细胞因子动物模型、制备方法及应用
US11715453B2 (en) 2019-12-25 2023-08-01 Ultraleap Limited Acoustic transducer structures
EP4096396A1 (en) * 2020-01-28 2022-12-07 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
WO2021216505A1 (en) 2020-04-21 2021-10-28 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cxcl13 gene
US11816267B2 (en) 2020-06-23 2023-11-14 Ultraleap Limited Features of airborne ultrasonic fields
WO2022058738A1 (en) 2020-09-17 2022-03-24 Ultraleap Limited Ultrahapticons
AU2022249328A1 (en) 2021-03-31 2023-09-21 Regeneron Pharmaceuticals, Inc. Genetically modified mice comprising humanized cellular immune system components with improved diversity of tcrβ repertoire
US12517585B2 (en) 2021-07-15 2026-01-06 Ultraleap Limited Control point manipulation techniques in haptic systems
WO2024073679A1 (en) 2022-09-29 2024-04-04 Regeneron Pharmaceuticals, Inc. Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes
WO2025212991A1 (en) 2024-04-05 2025-10-09 Regeneron Pharmaceuticals, Inc. Rodent models of disease
WO2025250495A1 (en) 2024-05-28 2025-12-04 Regeneron Pharmaceuticals, Inc. Acceleration of human hepatocyte engraftment in humanized liver animals by supplementing paracrine ligands or agonists that activate human liver regeneration signals

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2202549C (en) * 1994-10-14 2003-08-05 Tara Seshadri Transgenic nonhuman animal having functionally disrupted interleukin-1.beta. converting enzyme gene
CN1306963C (zh) 1994-10-21 2007-03-28 岸本忠三 用于治疗il-6产生所致疾病的药物组合物
US20030082721A1 (en) * 2001-01-17 2003-05-01 Tai-Jay Chang Transgenic animals expressing androgen receptor complex-associated protein
CN1560081A (zh) * 2004-02-17 2005-01-05 大连帝恩生物工程有限公司 用能产生人IgGl重链-κ轻链小鼠作为制备人源化单克隆抗体和应用
AU2005295269B2 (en) 2004-10-19 2010-05-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
ES2398076T3 (es) 2006-06-02 2013-03-13 Regeneron Pharmaceuticals, Inc. Anticuerpos de alta afinidad contra el receptor de IL-6 humano
ATE536374T1 (de) * 2006-09-01 2011-12-15 Therapeutic Human Polyclonals Inc Erhöhte expression von humanem oder humanisiertem immunglobulin bei nicht-humanen transgenen tieren
FR2942218A1 (fr) 2009-02-13 2010-08-20 Eurocave Sa Appareil de service au verre d'un liquide, notamment de vin
PT2485583T (pt) 2009-10-06 2016-09-22 Univ Yale Ratinhos geneticamente modificados e enxerto
PL3498730T3 (pl) * 2009-12-21 2026-04-07 Regeneron Pharmaceuticals, Inc. Humanizowane myszy fc gamma r
MX350385B (es) 2011-02-15 2017-09-04 Regeneron Pharma Ratones de m-csf humanizada.
TW201945034A (zh) * 2011-09-30 2019-12-01 日商中外製藥股份有限公司 包含依離子濃度之條件對抗原之結合活性會改變之抗原結合分域、及於pH中性之條件下對FcRn有結合活性之FcRn結合分域、且誘導對標的抗原的免疫反應之抗原結合分子
SI2770821T1 (en) 2011-10-28 2018-01-31 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex of mice
DK3590332T3 (da) 2011-10-28 2022-05-23 Regeneron Pharma Genmodificerede mus, der eksprimerer kimære major histokompatibilitetskompleks (MHC) II-molekyler
WO2013063556A1 (en) 2011-10-28 2013-05-02 Regeneron Pharmaceuticals, Inc. Humanized il-6 and il-6 receptor

Similar Documents

Publication Publication Date Title
JP2014532416A5 (https=)
WO2013063556A4 (en) Humanized il-6 and il-6 receptor
Pisitkun et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis
US11503813B2 (en) Humanized IL-15 animals
RU2014148107A (ru) Грызуны с гуманизированным il-7
Takemoto et al. Sycp2 is essential for synaptonemal complex assembly, early meiotic recombination and homologous pairing in zebrafish spermatocytes
RU2016123708A (ru) Отличные от человека животные, содержащие гуманизированный ген фактора активации в-клеток
SI3027015T1 (en) HUMANIZED IL-4 AND IL-4R ALPHA ANIMALS
JP2015510769A5 (https=)
RU2016123135A (ru) Отличные от человека животные, содержащие гуманизированный ген индуцирующего пролиферацию лиганда
JP2009524641A5 (https=)
NZ712508A (en) Non-human animals expressing ph-sensitive immunoglobulin sequences
Wang et al. Comparative evolutionary genomics of the STAT family of transcription factors
US11534502B2 (en) Genetically modified non-human animal with human or chimeric TIGIT
US20190373869A1 (en) GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD3e
Aida et al. Translating human genetics into mouse: The impact of ultra‐rapid in vivo genome editing
RU2018146313A (ru) Грызуны с условными мутантными аллелями acvr1
Eccles et al. Polycystic kidney disease–where gene dosage counts
RU2018109739A (ru) Трансгенное животное для получения антител, имеющих общую легкую цепь
Beatty et al. Comparative analysis of meningeal transcriptomes in birds: Potential pathways of resilience to repeated impacts
HK40006180A (en) Humanized il-15 animals
HK1233853B (en) Humanized il-15 animals
HK1233853A1 (en) Humanized il-15 animals
HK1210659B (en) Humanized il-15 animals